Hematology
News
CAR T-cell therapy found safe, effective for HIV-associated lymphoma
Two HIV-positive patients with chemotherapy-refractory, high-grade B-cell lymphoma achieved complete remission with anti-CD19 CAR T-cell therapy,...
Conference Coverage
Early post-ACS bleeding may signal cancer
PARIS – Cancer risk is elevated with bleeding, whether or not DAPT is employed
News
Hemophilia carriers face elevated risk of joint comorbidities
Individuals who carry hemophilia genes and have reduced clotting factor activity also have a higher risk of joint-related comorbidities.
News
ACOG advises bleeding disorder screening for teens with heavy menstruation
Bleeding disorders are found in approximately 20% of adolescent girls who present for evaluation of heavy menstrual bleeding and in 33% of...
FDA/CDC
Calquence earns breakthrough designation for CLL monotherapy
The Bruton tyrosine kinase inhibitor is already approved for the treatment of adults with mantle cell lymphoma who have received at least one...
News
Pretreatment CT data may help predict immunotherapy benefit in ovarian cancer
Fewer sites of disease and lower intratumor heterogeneity on contrast-enhanced CT may indicate a higher likelihood of durable response to immune...
News
Cancer survivors face more age-related deficits
Cancer survivors are more likely to experience age-related health deficits and increased mortality, compared with people without a history of...
News
Lower BMD found in patients with severe hemophilia A
The decrease in BMD was correlated with reduced functional ability and body mass index, and vitamin D insufficiency or deficiency.
News
Medicare’s CAR T-cell coverage decision draws praise, but cost issues linger
CMS officials have created a roadmap for coverage and payment for CAR T-cell therapies through a national coverage determination and the Medicare...
Conference Coverage
RNA interference drug fitusiran looks effective in both hemophilia A and B
MELBOURNE – The RNA interference drug fitusiran is associated with significant reductions in bleeding rates in patients with hemophilia A and B,...